Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.

J Thromb Thrombolysis · 2022 · PMC9362611 · PMID 35922578

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All secondary endpoints showed a trend in favour of full-dose anticoagulation as reported in Table 2 and Supplementary material Figs. 1–5.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.